Pages that link to "Q39261745"
Jump to navigation
Jump to search
The following pages link to Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells (Q39261745):
Displaying 30 items.
- RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer (Q21134105) (← links)
- Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets (Q28081193) (← links)
- Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi) (Q28534954) (← links)
- The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion (Q30641525) (← links)
- Effects of PTCs on nonsense-mediated mRNA decay are dependent on PTC location (Q33598210) (← links)
- miR‑196a‑5p modulates gastric cancer stem cell characteristics by targeting Smad4. (Q33699396) (← links)
- Expression of oncogenic K-ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cells (Q34101151) (← links)
- Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells (Q35067751) (← links)
- Loss of canonical Smad4 signaling promotes KRAS driven malignant transformation of human pancreatic duct epithelial cells and metastasis (Q35080923) (← links)
- RON(MST1R)is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma (Q35146597) (← links)
- A miRNA signature of chemoresistant mesenchymal phenotype identifies novel molecular targets associated with advanced pancreatic cancer (Q35237480) (← links)
- Deploying mouse models of pancreatic cancer for chemoprevention studies (Q35622126) (← links)
- Insights Into SMAD4 Loss in Pancreatic Cancer From Inducible Restoration of TGF-β Signaling (Q36107307) (← links)
- Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma (Q37040636) (← links)
- Crosstalk between RON and androgen receptor signaling in the development of castration resistant prostate cancer (Q37046523) (← links)
- Knockdown of RON receptor kinase delays but does not prevent tumor progression while enhancing HGF/MET signaling in pancreatic cancer cell lines (Q37275734) (← links)
- Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer (Q37746284) (← links)
- Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways (Q37809242) (← links)
- MSP-RON signalling in cancer: pathogenesis and therapeutic potential (Q38116308) (← links)
- SMAD4 and its role in pancreatic cancer (Q38281261) (← links)
- Cadherin-11 Is a Cell Surface Marker Up-Regulated in Activated Pancreatic Stellate Cells and Is Involved in Pancreatic Cancer Cell Migration (Q38290146) (← links)
- Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4. (Q39335687) (← links)
- The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance (Q42991719) (← links)
- Effects and mechanism of irbesartan on tubulointerstitial fibrosis in 5/6 nephrectomized rats (Q43162268) (← links)
- Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities (Q49887893) (← links)
- Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy (Q64093978) (← links)
- Automatic cell fusion via optically-induced dielectrophoresis and optically-induced locally-enhanced electric field on a microfluidic chip (Q88966500) (← links)
- Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy (Q90098540) (← links)
- Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer (Q91673432) (← links)
- Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer (Q92190792) (← links)